296 related articles for article (PubMed ID: 35637393)
1. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy.
Wolf NK; Kissiov DU; Raulet DH
Nat Rev Immunol; 2023 Feb; 23(2):90-105. PubMed ID: 35637393
[TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunity.
Rafei H; Daher M; Rezvani K
Br J Haematol; 2021 Apr; 193(2):216-230. PubMed ID: 33216984
[TBL] [Abstract][Full Text] [Related]
3. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
4. New avenues for melanoma immunotherapy: Natural Killer cells?
Cristiani CM; Garofalo C; Passacatini LC; Carbone E
Scand J Immunol; 2020 Apr; 91(4):e12861. PubMed ID: 31879979
[TBL] [Abstract][Full Text] [Related]
5. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
7. NK cells and ILCs in tumor immunotherapy.
Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells and other innate lymphoid cells in cancer.
Chiossone L; Dumas PY; Vienne M; Vivier E
Nat Rev Immunol; 2018 Nov; 18(11):671-688. PubMed ID: 30209347
[TBL] [Abstract][Full Text] [Related]
9. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
Lin C; Zhang J
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
[TBL] [Abstract][Full Text] [Related]
10. Harnessing adaptive natural killer cells in cancer immunotherapy.
Liu LL; Pfefferle A; Yi Sheng VO; Björklund AT; Béziat V; Goodridge JP; Malmberg KJ
Mol Oncol; 2015 Dec; 9(10):1904-17. PubMed ID: 26604011
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell biology: an update and future directions.
Campbell KS; Hasegawa J
J Allergy Clin Immunol; 2013 Sep; 132(3):536-544. PubMed ID: 23906377
[TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells and the MHC.
Robinette ML; Colonna M
HLA; 2016 Jan; 87(1):5-11. PubMed ID: 26812060
[TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells: the journey from puzzles in biology to treatment of cancer.
Bodduluru LN; Kasala ER; Madhana RM; Sriram CS
Cancer Lett; 2015 Feb; 357(2):454-67. PubMed ID: 25511743
[TBL] [Abstract][Full Text] [Related]
15. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
16. CD8
Uzhachenko RV; Shanker A
Front Immunol; 2019; 10():1906. PubMed ID: 31456803
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell-based strategies for immunotherapy of cancer.
Vaněk O; Kalousková B; Abreu C; Nejadebrahim S; Skořepa O
Adv Protein Chem Struct Biol; 2022; 129():91-133. PubMed ID: 35305726
[TBL] [Abstract][Full Text] [Related]
18. [Lectin populations of NK cells against tumors coupled to viral infections (review of literature).].
Lakhtin VM; Lakhtin MV; Mironov AY; Aleshkin VA; Аfanasiev SS
Klin Lab Diagn; 2019; 64(5):314-320. PubMed ID: 31185156
[TBL] [Abstract][Full Text] [Related]
19. Teleost T and NK cell immunity.
Fischer U; Koppang EO; Nakanishi T
Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867
[TBL] [Abstract][Full Text] [Related]
20. CAR-NK Cells: From Natural Basis to Design for Kill.
Khawar MB; Sun H
Front Immunol; 2021; 12():707542. PubMed ID: 34970253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
